RxDoctor Payments Data

Swati Patel, MD

Gastroenterology · Aurora, CONPI 1265640296

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Salix Pharmaceuticals, A Division Of Bausch Health US, LLC accounts for 70.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $125 and has fallen 66.5% since, to $42 in 2022. That places this record below the midpoint for gastroenterology clinicians in CO, where the typical reported total is $1,992.

$178in general payments, 2019–2025

Across 3 payments — averaging $59.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$125
  • Olympus America Inc.$42
  • ERBE USA Inc$11
$382,643in research payments, 2019–2025

Across 10 payments — averaging $38,264 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gyrus ACMI, Inc.$383K

What the payments were for

  • Food & beverage$178100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$178 in reported general payments places this provider in the 20th percentile of 304 gastroenterology providers in Colorado.

See all gastroenterology providers in Colorado

Medicare billing

Part B allowed, 2024
$9,685
Medicare patients
43
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole12$98

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →